Bedoradrine
Product Specifications
UNSPSC Description
Bedoradrine is a highly selective β2-adrenergic agonist with activity in suppressing asthma and chronic obstructive pulmonary disease (COPD). Bedoradrine is administered by intravenous infusion and is specifically indicated for the suppression of acute asthma attacks. Bedoradrine has shown good safety and preliminary efficacy in clinical trials, especially in patients with stable moderate to severe asthma. The results of Bedoradrine studies have shown that it can provide clinical benefits without increasing clinical risks, especially for patients who are unable to use inhalation or nebulization suppression[1].
Target Antigen
Adrenergic Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein;Neuronal Signaling
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Endocrinology
Assay Protocol
https://www.medchemexpress.com/bedoradrine.html
Smiles
O[C@H](C1=CC(CCO)=C(C=C1)O)CN[C@@H]2CC3=CC(OCC(N(C)C)=O)=CC=C3CC2
Molecular Weight
428.52
References & Citations
[1]Evaluation of bedoradrine sulfate (MN-221), a novel, highly selective beta2-adrenergic receptor agonist for the treatment of asthma via intravenous infusion
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-14915/Bedoradrine-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-14915/
Clinical Information
Phase 4
CAS Number
194785-19-8
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
RR201550L3V 200 µL
LOC685544 (NM_001109474) Rat Tagged ORF Clone Lentiviral Particle
Ask
View Details 
